Pharma Talks

Pharma Talks

Nataliya Andreychuk
Country USA
Language EN
Episodes 35
Latest 20.11.2026

Join Nataliya Andreychuk, CEO of Viseven, on Pharma Talks – a podcast where human voices meet industry insights. Dive into engaging conversations with industry leaders, exploring the latest trends in pharma marketing, digital transformation, and AI-driven solutions.

Episodes

  • Pharma Talks with Nataliya Andreychuk | Live from Fierce Pharma Week | Kelly Duffort
    Pharma Talks with Nataliya Andreychuk | Live from Fierce Pharma Week | Kelly Duffort 20.11.2026 12m
    Pharma Talks with Nataliya Andreychuk | Live from Fierce Pharma Week | Kelly DuffortRecorded live at Fierce Pharma Week in Philadelphia, Nataliya Andreychuk talks with Kelly Duffort, Associate Director of Media, Azurity Pharmaceuticals, about whether AI can close the gap between medical and commercial teams. Kelly approaches it as a media and digital marketer, separating what AI can connect from what people still need to decide.Key takeaways:AI’s real value here is joining data both sides hold separately and surfacing signals each saw only in partShared intelligence is not shared decision-maki...
  • Pharma Talks with Nataliya Andreychuk | Live from Fierce Pharma Week | Ned Ehrbar
    Pharma Talks with Nataliya Andreychuk | Live from Fierce Pharma Week | Ned Ehrbar 11.11.2026 6m
    In this episode recorded live at Fierce Pharma Week, Nataliya Andreychuk speaks with Ned Ehrbar, Director of Global Media Relations at Merck, about AI in pharma, medical-commercial collaboration, and the future of omnichannel pharmaceutical marketing.They discuss why technology alone isn't enough, how workforce upskilling and new habits drive adoption, and why accurate, accessible, up-to-date information must remain at the center of every patient experience.📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Join our community: https://pharmatalks.cir...
  • Pharma's Content Graveyard: Can AI Fix the Problem? | Pharma Talks with Nataliya Andreychuk | Part 2
    Pharma's Content Graveyard: Can AI Fix the Problem? | Pharma Talks with Nataliya Andreychuk | Part 2 04.11.2026 17m
    In Part 2 of this Pharma Talks episode, Nataliya Andreycuk continues her conversation with Rasmus Kalms, technologist and product leader, exploring the practical steps pharma teams can take to move beyond content production bottlenecks.00:00 Rethinking the pharma content lifecycle with AI 03:41 Can early MLR approval cut content approval time by 50%? 07:00 Connecting platforms, teams and global content governance 10:54 Hot or Not 14:54 Delivering relevant, trustworthy content at the speed of need 16:13 Final advice: Don't be afraid to experiment📲 Enjoyed this episode?👉 Like, Subscribe & hit...
  • Pharma's Content Graveyard: Can AI Fix the Problem? | Pharma Talks with Nataliya Andreychuk | Part 1
    Pharma's Content Graveyard: Can AI Fix the Problem? | Pharma Talks with Nataliya Andreychuk | Part 1 30.10.2026 18m
    Pharma doesn't necessarily need more content. It needs content that teams can find, reuse, adapt, and deliver when it's needed.In Part 1 of this Pharma Talks conversation, Nataliya Andreycuk sits down with Rasmus Kalms, technologist and product leader, to challenge the way pharma approaches content production, modular content, and AI.Why do content management practices that work in other industries often look different in pharma? Can generative AI solve the problem of fragmented content libraries? And is modular content really dead — or have we simply made it too complicated?Rasmus shares his...
  • The Trust Paradox in Pharma l Pharma Talks with Nataliya Andreychuk
    The Trust Paradox in Pharma l Pharma Talks with Nataliya Andreychuk 22.10.2026 22m
    Nataliya Andreychuk sits down with Raphael Blum, oncology commercial executive and former VP, Global Commercial Development Oncology at AbbVie, to look at why an industry that saves lives still struggles to earn public trust. After more than 20 years at Pfizer, Merck Serono and AbbVie, starting as a medical rep, Raphael has worked on both sides of the trust gap: in headquarters and in the field.Key takeaways:Trust in a medicine or a physician is different from trust in a company or an industryExplaining risk has never been enough, because patients judge pharma through access, affordability and...
  • AI Is Changing SaaS in Pharma: From Software Seats to Outcomes | Pharma Talks with Nataliya Andreychuk
    AI Is Changing SaaS in Pharma: From Software Seats to Outcomes | Pharma Talks with Nataliya Andreychuk 14.10.2026 27m
    AI is changing more than the technology inside pharma's software stack. It is challenging the entire SaaS model: how software is built, how workflows are designed, how teams work, and what customers should actually pay for.In this episode of Pharma Talks, Nataliya Andreychuk sits down with Thomas Mrosk, a pharma and AI transformation expert and co-founder of CTC Health, to explore what is changing — and what pharma needs to rethink next.From fragmented point solutions and traditional SaaS models to agentic AI, internal capabilities and AI-powered education, this conversation asks a bigger ques...
  • From Systematic to Automatic: Scaling AI Without Breaking Its Content Ecosystem | Pharma Talks with Nataliya Andreychuk
    From Systematic to Automatic: Scaling AI Without Breaking Its Content Ecosystem | Pharma Talks with Nataliya Andreychuk 07.10.2026 28m
    In this episode of Pharma Talks, Nataliya Andreychuk sits down with Toby Beaumont, a commercial digital transformation expert who has spent around 20 years working across pharma, agencies, and the vendor side, to unpack one of the biggest challenges facing pharma marketing today:AI can generate content faster than ever. But what happens when you put a faster engine into a broken car?The conversation explores what pharma needs to fix before it can truly scale AI — and what it could mean for the future of pharma marketing and the marketer of tomorrow.00:00 Systematic to Automatic — Why AI Alone...
  • Experience as a Medicine: Rethinking Patient Experience in Pharma | Pharma Talks with Nataliya Andreychuk | Part 2
    Experience as a Medicine: Rethinking Patient Experience in Pharma | Pharma Talks with Nataliya Andreychuk | Part 2 30.09.2026 21m
    In Part 2 of this Pharma Talks conversation, Nataliya Andreychuk and Richard Schwartz continue their discussion about why experience is medicine — and explore what technology, data, and AI could mean for the future of healthcare experiences.From rethinking brand websites and using AI to understand the questions patients are really asking, to challenging pharma's approach to HCP engagement, patient support, and measurement, Richard argues that the industry has an opportunity to create experiences that are as sophisticated as the science behind the medicines.The conversation also explores the po...
  • Experience as a Medicine: Rethinking Patient Experience in Pharma | Pharma Talks with Nataliya Andreychuk | Part 1
    Experience as a Medicine: Rethinking Patient Experience in Pharma | Pharma Talks with Nataliya Andreychuk | Part 1 23.09.2026 25m
    What happens between a pharmaceutical product and the patient who needs it?In Part 1 of this Pharma Talks conversation, Nataliya Andreychuk sits down with Richard Schwartz, a healthcare and pharmaceutical industry expert with three decades of experience across pharma, consulting, agencies, publishing and technology, to explore one of the industry's biggest blind spots: the experience surrounding the medicine.The conversation goes deeper into trust in pharma, patient-centricity, healthcare customer experience, patient support programs and why experience should be treated as part of the product...
  • The AI Investment Producing the Wrong Results in Pharma | Pharma Talks with Nataliya Andreychuk
    The AI Investment Producing the Wrong Results in Pharma | Pharma Talks with Nataliya Andreychuk 09.09.2026 15m
    In this solo episode of Pharma Talks, Nataliya Andreychuk takes an unfiltered look at one of the biggest challenges emerging from AI adoption in the pharmaceutical industry: the velocity trap.Pharma is investing billions in artificial intelligence, accelerating content production, expanding into new channels, and making localization easier than ever. Yet at the same time, huge volumes of approved content are never used.Nataliya explores what happens when AI-powered content creation moves faster than the workflows, relationships, and human expertise needed to make that content meaningful. She l...
  • AI-Native Talent: The Future of Pharma Jobs & Recruitment | Pharma Talks with Nataliya Andreychuk
    AI-Native Talent: The Future of Pharma Jobs & Recruitment | Pharma Talks with Nataliya Andreychuk 26.08.2026 26m
    Steve Swan returns to Pharma Talks for a conversation about what has changed in pharma talent and recruitment since his last conversation with Nataliya Andreychuk a year ago.And the answer is: a lot.AI is now writing job descriptions, tailoring resumes, screening candidates — and, in some cases, essentially creating an AI-versus-AI recruitment loop. The result? Hundreds of polished applications, but not necessarily more people who can actually do the job.With nearly 30 years of experience hiring across pharma and biotech, Steve shares what he is seeing from the front lines — from the growing d...
  • Commercial and Medical Alignment in Pharma | Pharma Talks with Nataliya Andreychuk | Part 2
    Commercial and Medical Alignment in Pharma | Pharma Talks with Nataliya Andreychuk | Part 2 19.08.2026 23m
    Part 2 of this Pharma Talks conversation with Elaine Gamble moves from identifying the challenges of Commercial and Medical collaboration to the practical steps organizations can take to create connected customer experiences.The discussion explores how AI, next best action, customer data, and organizational culture can help pharma teams work as one — without compromising compliance or scientific integrity. 📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode.👉 Want to be a guest? Plan your recording with Nataliya Andreychuk. 🔗 Follow & Connect: 🎙️ Nata...
  • Commercial and Medical Alignment in Pharma | Pharma Talks with Nataliya Andreychuk | Part 1
    Commercial and Medical Alignment in Pharma | Pharma Talks with Nataliya Andreychuk | Part 1 13.08.2026 20m
    Elaine Gamble, customer engagement leader, omnichannel strategist, and former executive at Merck, Novartis, Otsuka, and other leading pharmaceutical companies, joins Nataliya Andreychuk on Pharma Talks to explore why stronger collaboration between Commercial and Medical has become essential for delivering connected, compliant, and customer-centric engagement.In Part 1, Elaine explains why silos still exist despite years of digital transformation—and why technology isn't the biggest barrier.Key takeaways:Commercial and Medical teams often share the same goals but operate through transactional r...
  • AI in Pharma Omnichannel: From Strategy to Execution l Pharma Talks with Nataliya Andreychuk l Part 2
    AI in Pharma Omnichannel: From Strategy to Execution l Pharma Talks with Nataliya Andreychuk l Part 2 05.08.2026 21m
    Part 2 of this Pharma Talks conversation with Matteo Colonna picks up where strategy meets execution — moving from the "why" of omnichannel and AI to the practical realities of making it work inside pharma organizations.📲 Enjoyed this episode?👉 Like, Subscribe & hit the 🔔 to never miss a Pharma Talks episode👉 Want to be a guest? Plan your recording with Nataliya Andreychuk🔗 Follow & Connect: 🎙️ Nataliya Andreychuk → https://www.linkedin.com/in/andreychuk/ 🎙️ Matteo Colonna → https://www.linkedin.com/in/colonnamatteo/
  • AI in Pharma Omnichannel: From Strategy to Execution l Pharma Talks with Nataliya Andreychuk l Part 1
    AI in Pharma Omnichannel: From Strategy to Execution l Pharma Talks with Nataliya Andreychuk l Part 1 30.07.2026 18m
    Matteo Colonna, an omnichannel transformation practitioner with a background in theoretical physics from Sapienza University in Rome and experience across consulting, digital agencies, and two major pharma companies, joins Nataliya Andreychuk on Pharma Talks to unpack why omnichannel and AI have moved from "nice to have" to business necessity.Key takeaways:Customer behavior and expectations have fundamentally shifted — pharma companies can no longer design omnichannel experiences without first understanding what customers actually need and prefer.Technology should never be the starting point —...
  • The Impact of AI on Jobs l Pharma Talks with Nataliya Andreychuk
    The Impact of AI on Jobs l Pharma Talks with Nataliya Andreychuk 22.07.2026 15m
    Karol Wolak, Director and Global Omnichannel Excellence Lead at Merck, joins Nataliya Andreychuk on Pharma Talks to tackle a question on everyone's mind: is AI coming for pharma jobs? His perspective is grounded in hands-on work across customer engagement and digital transformation at one of the industry's largest organizations.Views shared are Karol Wolak's own and do not represent an official position of Merck.Key takeaways:AI isn't replacing pharma roles anytime soon — it's better positioned to absorb repetitive back-office work like content tagging, MLR approval, and data collection.Human...
  • Agentic AI in Pharma: Are We Ready for AI That Acts? l Pharma Talks with Nataliya Andreychuk
    Agentic AI in Pharma: Are We Ready for AI That Acts? l Pharma Talks with Nataliya Andreychuk 17.07.2026 24m
    Agentic AI has moved pharma from answering questions to autonomously orchestrating entire workflows — but most organisations are still building the foundations it needs to run well. In this episode, Nataliya Andreychuk talks with Michal Dojlidko about what agentic AI actually requires in practice: the right data, the right guardrails, continuous upskilling, and a clear-eyed view of where humans still belong in the loop.Key topicsEvolution of AI in pharma from answering questions to autonomous workflowsImportance of trust and data foundations in AI adoptionRegulatory considerations and human ov...
  • How to Build an Omnichannel Strategy in Pharma l Pharma Talks with Nataliya Andreychuk
    How to Build an Omnichannel Strategy in Pharma l Pharma Talks with Nataliya Andreychuk 08.07.2026 40m
    Michael Kirzhner, Omnichannel Platforms and Capabilities Leader at AbbVie, joins Nataliya Andreychuk to discuss the real state of omnichannel in pharma — what the industry has built, what's still missing, and where the next evolution lies.Michael has spent over a decade navigating the shift from field-centric models to digital-first orchestration inside one of the world's largest pharma companies.In this episode:Omnichannel fragmentation starts with departments, not technology — the coordination layer is what pharma hasn't built yetMost companies are strong at functional execution but lack a c...
  • Pharma Talks with Nataliya Andreychuk | Live from NEXT Pharma Summit | Jennifer Cleall
    Pharma Talks with Nataliya Andreychuk | Live from NEXT Pharma Summit | Jennifer Cleall 02.07.2026 5m
    In this episode of Pharma Talks, recorded live at NEXT Pharma Summit in Dubrovnik, Nataliya Andreychuk speaks with Jennifer Cleall, Global Head of Digital Transformation at Ferring Pharmaceuticals, on what it actually takes to align medical and commercial teams — and where AI fits into that picture.Jennifer brings cross-industry perspective spanning pharma, med tech, and enterprise technology.Key takeaways:AI won't take our jobs — but being deliberate about where and why you apply it is what separates progress from noiseBefore layering in AI, organizations need to simplify processes and system...
  • Breaking Pharma Silos: Strategies for Cross-Functional Success l Pharma Talks
    Breaking Pharma Silos: Strategies for Cross-Functional Success l Pharma Talks 24.06.2026 19m
    In this episode Laragh De Bhulbh shares her expertise on breaking down silos within pharma organizations, fostering cross-functional collaboration, and implementing strategic frameworks to enhance medical affairs. Discover practical tips for leaders and the importance of trust, communication, and strategic alignment in driving patient impact.Key topics:- Cross-functional collaboration challenges in pharma- The Catalyst framework for alignment- Leadership strategies for medical affairs- The role of trust and communicationChapters00:00 Introduction to Laragh De Bhulbh and her expertise01:24 Lara...

Popular in

The podcast also appears in the podcast charts of these countries.